Trials / Unknown
UnknownNCT02137616
Antipsychotic to Treat Psychosis Syndrome
Effectiveness of Antipsychotic Drugs to Treat Psychosis Syndrome: an Open Label, Controlled Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Central South University · Academic / Other
- Sex
- All
- Age
- 16 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
This study assess the safety and effects of atypical antipsychotics in subjects with psychosis syndrome and psychosis risk syndrome.
Detailed description
The investigators investigated whether administration of atypical antipsychotics could alleviate prodromal symptoms and be well tolerated by subjects with psychosis syndrome and psychosis risk syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | risperidone | Risperdal tablets |
| DRUG | olanzapine | olanzapine tablets |
| DRUG | Quetiapine | quetiapine tablets |
| DRUG | Aripiprazole | Aripiprazole tablets |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-05-14
- Last updated
- 2014-05-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02137616. Inclusion in this directory is not an endorsement.